Corient Capital Partners, LLC Danaher Corp Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Danaher Corp stock. As of the latest transaction made, Corient Capital Partners, LLC holds 17,851 shares of DHR stock, worth $4.31 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

17,851

Previous 17,851 -0.0%

Holding current value

$4.31 Million

Previous $4.53 Million -0.0%

% of portfolio

0.34%

Previous 0.34%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$237.11 - $299.66 $386,963 - $489,045	1,632 Added 10.06%	17,851 $4.53 Million
Q1 2022 May 16, 2022	SELL	$257.27 - $315.76 $190,379 - $233,662	-740 Reduced 4.36%	16,219 $4.76 Million
Q4 2021 Feb 11, 2022	SELL	$292.08 - $329.01 $242,134 - $272,749	-829 Reduced 4.66%	16,959 $5.58 Million
Q3 2021 Nov 16, 2021	SELL	$272.21 - $332.43 $25,315 - $30,915	-93 Reduced 0.52%	17,788 $5.42 Million
Q2 2021 Aug 16, 2021	BUY	$225.08 - $271.69 $81,929 - $98,895	364 Added 2.08%	17,881 $4.8 Million
Q1 2021 May 17, 2021	SELL	$212.38 - $245.9 $30,795 - $35,655	-145 Reduced 0.82%	17,517 $3.94 Million
Q4 2020 Feb 12, 2021	SELL	$212.5 - $245.46 $1.12 Million - $1.29 Million	-5,269 Reduced 22.98%	17,662 $3.92 Million
Q3 2020 Nov 16, 2020	SELL	$177.16 - $215.33 $91,237 - $110,894	-515 Reduced 2.2%	22,931 $4.94 Million
Q2 2020 Aug 14, 2020	BUY	$128.7 - $176.83 $14,414 - $19,804	112 Added 0.48%	23,446 $4.15 Million
Q1 2020 May 06, 2020	SELL	$121.39 - $169.05 $210,490 - $293,132	-1,734 Reduced 6.92%	23,334 $3.23 Million
Q4 2019 Feb 04, 2020	BUY	$133.47 - $153.48 $1.05 Million - $1.21 Million	7,864 Added 45.71%	25,068 $3.85 Million
Q3 2019 Nov 06, 2019	SELL	$135.4 - $146.47 $4,062 - $4,394	-30 Reduced 0.17%	17,204 $2.49 Million
Q2 2019 Aug 08, 2019	SELL	$124.88 - $143.73 $171,460 - $197,341	-1,373 Reduced 7.38%	17,234 $2.46 Million
Q1 2019 May 10, 2019	SELL	$97.62 - $132.29 $433,628 - $587,632	-4,442 Reduced 19.27%	18,607 $2.46 Million
Q4 2018 Feb 07, 2019	BUY	$94.85 - $109.54 $381,581 - $440,679	4,023 Added 21.14%	23,049 $2.38 Million
Q2 2018 Oct 02, 2018	BUY	$96.1 - $103.24 $230,640 - $247,776	2,400 Added 14.44%	19,026 $1.88 Million
Q1 2018 May 14, 2018	BUY	$92.16 - $103.8 $226,990 - $255,659	2,463 Added 17.39%	16,626 $1.63 Million
Q4 2017 Feb 13, 2018	BUY	$85.26 - $94.62 $99,072 - $109,948	1,162 Added 8.94%	14,163 $1.31 Million
Q3 2017 Nov 14, 2017	SELL	$79.29 - $88.45 $421,505 - $470,200	-5,316 Reduced 29.02%	13,001 $0
Q2 2017 Aug 14, 2017	BUY	N/A	516 Added 2.9%	18,317 $1.55 Million
Q1 2017 Aug 17, 2017	SELL	N/A	-8,233 Reduced 31.62%	17,801 $1.52 Million
Q1 2017 Aug 14, 2017	BUY	N/A	26,034	26,034 $3.42 Million

Others Institutions Holding DHR

# of Institutions

2,481

Shares Held

547M

Call Options Held

4.07M

Put Options Held

4.01M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $176B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Danaher Corp Transaction History